| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Max Wygod Family Dynasty Trust | 10%+ Owner | $9,557,592 | 14 Feb 2022 | ||
| Adam H. Dublin | Chief Strategy Officer, Director | $8,994,621 | 15 Jul 2025 | ||
| Martin J. Wygod | Director | $6,171,947 | 04 Oct 2023 | ||
| Edward Francis Spaniel Jr. | EVP, Gen Counsel & Secretary | $5,781,887 | 05 Mar 2025 | ||
| Max C. Wygod | Exec Chairman, CEO & President, Director, 10%+ Owner | $2,950,829 | 15 Jul 2025 | ||
| Michael Vesey | Chief Financial Officer | $1,238,181 | 13 Feb 2026 | ||
| Caroline Strickland McGrail | General Counsel | $336,000 | 02 Nov 2025 | ||
| Alyssa F. Varadhan | Director | 26 Mar 2025 | |||
| Shahir Kassam-Adams | Director | 26 Mar 2025 | |||
| Jennifer Hajj | Director | 26 Mar 2025 | |||
| Kristiina Vuori MD | Director | 26 Mar 2025 | |||
| Ian Banwell | Director | 26 Mar 2025 | |||
| Stanley S. Trotman Jr. | Director | 26 Mar 2025 | |||
| Mark J. Adler MD | Director | 26 Mar 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael Vesey | FORA | Common Stock | Tax liability | -0.83% | -4,918 | 589,610 | 13 Feb 2026 | Direct | ||
| Michael Vesey | FORA | Common Stock | Tax liability | -2.95% | -18,077 | 594,528 | 12 Jan 2026 | Direct | ||
| Michael Vesey | FORA | Common Stock | Tax liability | -2.82% | -17,777 | 612,605 | 10 Nov 2025 | Direct | ||
| Caroline Strickland McGrail | FORA | Common Stock | Award | 150,000 | 150,000 | 02 Nov 2025 | Direct | |||
| Michael Vesey | FORA | Common Stock | Tax liability | -0.52% | -3,300 | 630,382 | 02 Sep 2025 | Direct | ||
| Michael Vesey | FORA | Common Stock | Award | 46.1% | 200,000 | 633,682 | 15 Jul 2025 | Direct | ||
| Max C. Wygod | FORA | Common Stock | Award | 15% | 200,000 | 1,528,927 | 15 Jul 2025 | Direct | ||
| Adam H. Dublin | FORA | Common Stock | Award | 7.98% | 200,000 | 2,705,533 | 15 Jul 2025 | Direct | ||
| Shahir Kassam-Adams | FORA | Stock Option (right to buy) | Award | 15,000 | 15,000 | 26 Mar 2025 | Direct | |||
| Alyssa F. Varadhan | FORA | Stock Option (right to buy) | Award | 15,000 | 15,000 | 26 Mar 2025 | Direct | |||
| Jennifer Hajj | FORA | Stock Option (right to buy) | Award | 15,000 | 15,000 | 26 Mar 2025 | Direct | |||
| Kristiina Vuori MD | FORA | Stock Option (right to buy) | Award | 15,000 | 15,000 | 26 Mar 2025 | Direct | |||
| Ian Banwell | FORA | Stock Option (right to buy) | Award | 15,000 | 15,000 | 26 Mar 2025 | Direct | |||
| Stanley S. Trotman Jr. | FORA | Stock Option (right to buy) | Award | 15,000 | 15,000 | 26 Mar 2025 | Direct | |||
| Mark J. Adler MD | FORA | Stock Option (right to buy) | Award | 15,000 | 15,000 | 26 Mar 2025 | Direct |